Tivic Health Systems Inc
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
VBIO$0.51+1.6%Stored close · as of Nov 6, 2026
Contents
Statements of Operations
(in thousands, except share and per share data)
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue | $1,176 | $1,840 |
| Cost of sales | 889 | 1,541 |
| Gross profit | 287 | 299 |
| Operating expenses: | ||
| Research and development | 1,655 | 1,730 |
| Sales and marketing | 2,125 | 2,792 |
| General and administrative | 4,752 | 5,875 |
| Total operating expenses | 8,532 | 10,397 |
| Loss from operations | (8,245) | (10,098) |
| Other income: | ||
| Interest income | 1 | 2 |
| Total other income | 1 | 2 |
| Net loss before income taxes | $(8,244) | $(10,096) |
| Net loss per share - basic and diluted | $(10.40) | $(104.32) |
| Weighted-average number of shares - basic and diluted | 793,043 | 96,778 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.